{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T00:22:27Z","timestamp":1708820547022},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,24]]},"DOI":"10.7759\/cureus.54831","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T21:25:36Z","timestamp":1708809936000},"source":"Crossref","is-referenced-by-count":0,"title":["Novel Use of Clonidine Patch to Treat Tizanidine Withdrawal"],"prefix":"10.7759","author":[{"given":"Aaron B","family":"Deutsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare F","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis P","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie E","family":"Ebeling-Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian A","family":"Beauchamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth D","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Tizanidine","author":"Ghanavatian S","year":"2024","unstructured":"Ghanavatian S, Derian A. Tizanidine. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30852-7","article-title":"New directions in the treatment of opioid withdrawal","volume":"395","author":"Srivastava AB","year":"2020","unstructured":"Srivastava AB, Mariani JJ, Levin FR. New directions in the treatment of opioid withdrawal. Lancet. 2020, 395:1938-48. 10.1016\/S0140-6736(20)30852-7","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713001600","article-title":"Abuse liability of centrally acting non-opioid analgesics and muscle relaxants - a brief update based on a comparison of pharmacovigilance data and evidence from the literature","volume":"17","author":"Gahr M","year":"2014","unstructured":"Gahr M, Freudenmann RW, Eller J, Sch\u00f6nfeldt-Lecuona C. Abuse liability of centrally acting non-opioid analgesics and muscle relaxants - a brief update based on a comparison of pharmacovigilance data and evidence from the literature. Int J Neuropsychopharmacol. 2014, 17:957-9. 10.1017\/S1461145713001600","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/14659891.2020.1738574","article-title":"Using clonidine in the treatment of tizanidine abuse and withdrawal: a case report of a patient with somatoform pain disorder","volume":"25","author":"Kitta A","year":"2020","unstructured":"Kitta A, Wippel A, Richwien P, et al.. Using clonidine in the treatment of tizanidine abuse and withdrawal: a case report of a patient with somatoform pain disorder. J Subst Use. 2020, 25:535-7. 10.1080\/14659891.2020.1738574","journal-title":"J Subst Use"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/1179547618758022","article-title":"Management of tizanidine withdrawal syndrome: a case report","volume":"11","author":"Su\u00e1rez-Lled\u00f3 A","year":"2018","unstructured":"Su\u00e1rez-Lled\u00f3 A, Padull\u00e9s A, Lozano T, Cobo-Sacrist\u00e1n S, Colls M, J\u00f3dar R. Management of tizanidine withdrawal syndrome: a case report. Clin Med Insights Case Rep. 2018, 11:10.1177\/1179547618758022","journal-title":"Clin Med Insights Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49248","article-title":"A case of tizanidine withdrawal syndrome: features and management in the emergency department","volume":"15","author":"Morgom M","year":"2023","unstructured":"Morgom M, Sabir DM, Elbashir H, Saeed L, Alamin A, Abuazab Y, Abdelrahman N. A case of tizanidine withdrawal syndrome: features and management in the emergency department. Cureus. 2023, 15:10.7759\/cureus.49248","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-022-01356-1","article-title":"Management of tizanidine abuse and withdrawal in a 53-year-old woman: a case report","volume":"5","author":"Daniels FN","year":"2023","unstructured":"Daniels FN, Ridwan R, Vasileva AD. Management of tizanidine abuse and withdrawal in a 53-year-old woman: a case report. SN Compr Clin Med. 2023, 5:10.1007\/s42399-022-01356-1","journal-title":"SN Compr Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1399167","article-title":"Tizanidine withdrawal symptoms in stress cardiomyopathy. [Article in German]","volume":"83","author":"M\u00f6rkl S","year":"2015","unstructured":"M\u00f6rkl S, Bengesser SA, Sch\u00f6ggl H, Bayer D, Kapfhammer HP. Tizanidine withdrawal symptoms in stress cardiomyopathy. [Article in German]. Fortschr Neurol Psychiatr. 2015, 83:170-3. 10.1055\/s-0034-1399167","journal-title":"Fortschr Neurol Psychiatr"},{"key":"ref9","article-title":"Clonidine","author":"Yasaei R","year":"2023","unstructured":"Yasaei R, Saadabadi A. Clonidine. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref10","article-title":"Withdrawal management","year":"2009","unstructured":"Withdrawal management. Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings. WHO Press, Geneva, Switzerland; 2009. 29-50."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/1658-354X.125955","article-title":"Clonidine for management of chronic pain: a brief review of the current evidences","volume":"8","author":"Kumar A","year":"2014","unstructured":"Kumar A, Maitra S, Khanna P, Baidya DK. Clonidine for management of chronic pain: a brief review of the current evidences. Saudi J Anaesth. 2014, 8:92-6. 10.4103\/1658-354X.125955","journal-title":"Saudi J Anaesth"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2005.04133.x","article-title":"Transdermal clonidine: therapeutic considerations","volume":"7","author":"Sica DA","year":"2005","unstructured":"Sica DA, Grubbs R. Transdermal clonidine: therapeutic considerations. J Clin Hypertens (Greenwich). 2005, 7:558-62. 10.1111\/j.1524-6175.2005.04133.x","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002024.pub5","article-title":"Alpha 2-adrenergic agonists for the management of opioid withdrawal","volume":"2016","author":"Gowing L","year":"2016","unstructured":"Gowing L, Farrell M, Ali R, White JM. Alpha 2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev. 2016, 2016:10.1002\/14651858.CD002024.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.6.5_pt_2.ii71","article-title":"Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists","volume":"6","author":"Reid JL","year":"1984","unstructured":"Reid JL, Campbell BC, Hamilton CA. Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists. Hypertension. 1984, 6:71-5. 10.1161\/01.hyp.6.5_pt_2.ii71","journal-title":"Hypertension"},{"key":"ref15","article-title":"Effects of tizanidine in healthy volunteers: double-blind study compared with diazepam and a placebo","volume":"8","author":"Yanagita T","year":"1988","unstructured":"Yanagita T, Yamamura H, Igarashi S. Effects of tizanidine in healthy volunteers: double-blind study compared with diazepam and a placebo. Int J Clin Pharmacol Res. 1988, 8:75-94.","journal-title":"Int J Clin Pharmacol Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1081\/clt-200026978","article-title":"Retrospective review of tizanidine (Zanaflex) overdose","volume":"42","author":"Spiller HA","year":"2004","unstructured":"Spiller HA, Bosse GM, Adamson LA. Retrospective review of tizanidine (Zanaflex) overdose. J Toxicol Clin Toxicol. 2004, 42:593-6. 10.1081\/clt-200026978","journal-title":"J Toxicol Clin Toxicol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-021-00235-2","article-title":"Management of musculoskeletal pain: an update with emphasis on chronic musculoskeletal pain","volume":"10","author":"El-Tallawy SN","year":"2021","unstructured":"El-Tallawy SN, Nalamasu R, Salem GI, LeQuang JA, Pergolizzi JV, Christo PJ. Management of musculoskeletal pain: an update with emphasis on chronic musculoskeletal pain. Pain Ther. 2021, 10:181-209. 10.1007\/s40122-021-00235-2","journal-title":"Pain Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/213364-novel-use-of-clonidine-patch-to-treat-tizanidine-withdrawal","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T21:25:39Z","timestamp":1708809939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/213364-novel-use-of-clonidine-patch-to-treat-tizanidine-withdrawal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,24]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.54831","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,24]]}}}